PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data. Moutafi M, Economopoulou P, Rimm D, Psyrri A, et al. Oral Oncol 2021;117:105292.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Moutafi M, Economopoulou P, Rimm D, Psyrri A, et al. PARP inhibitors in head and neck cancer: Molecular mechanisms, preclinical and clinical data. Oral Oncol 2021;117:105292.
PMID: 33862558